4日前 -Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries.
2024/10/24 -Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the ...
2024/10/21 -Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of ...
エーザイ ＝2024年9月中間連結決算（国際会計基準）は増収減益。抗がん剤「レンビマ」やアルツハイマー病治療薬「レケンビ（一般名レカネマブ）」などの主力品が売り上げを伸ばしたが、製品の権利譲渡に伴う一時的...
時事通信-
2日前 -Eisai on Friday slashed its full-year sales forecast for Leqembi amid ongoing struggles to make headway with the Alzheimer's disease therapy in the US.
5日前 -Kisunla is a once-monthly injection treatment indicated for adults with early symptomatic Alzheimer's, including mild cognitive impairment, or mild dementia ...
2024/8/15 -Learn how LEQEMBI keeps fighting throughout treatment to remove harmful amyloid brain plaque. Watch how LEQEMBI works on fighting Alzheimer's disease in 2 ways.
2024/9/14 -OncologyPRO is the home of ESMO's educational & scientific resources, with exclusive content for ESMO members such as ESMO's Congresses webcasts,
2024/8/15 -LEQEMBI Companion is a website experience filled with useful information, engaging resources, and helpful tips to return to throughout treatment.
2024/9/7 -Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD clinical trial.
2024/9/6 -1008 位粉丝、已关注 2849 人、 317 篇帖子 - Instagram 用户 eisai (@eisai.s1016)：“✳︎日本デコラージュ協会クラフトマイスター認定講師✳︎KEA認定講師-実技講座 ...